Literature DB >> 24972706

Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes.

Sophie Tezenas du Montcel1, Alexandra Durr2, Peter Bauer3, Karla P Figueroa4, Yaeko Ichikawa5, Alessandro Brussino6, Sylvie Forlani7, Maria Rakowicz8, Ludger Schöls9, Caterina Mariotti10, Bart P C van de Warrenburg11, Laura Orsi12, Paola Giunti13, Alessandro Filla14, Sandra Szymanski15, Thomas Klockgether16, José Berciano17, Massimo Pandolfo18, Sylvia Boesch19, Bela Melegh20, Dagmar Timmann21, Paola Mandich22, Agnès Camuzat7, Jun Goto5, Tetsuo Ashizawa23, Cécile Cazeneuve24, Shoji Tsuji5, Stefan-M Pulst4, Alfredo Brusco6, Olaf Riess3, Alexis Brice25, Giovanni Stevanin26.   

Abstract

Polyglutamine-coding (CAG)n repeat expansions in seven different genes cause spinocerebellar ataxias. Although the size of the expansion is negatively correlated with age at onset, it accounts for only 50-70% of its variability. To find other factors involved in this variability, we performed a regression analysis in 1255 affected individuals with identified expansions (spinocerebellar ataxia types 1, 2, 3, 6 and 7), recruited through the European Consortium on Spinocerebellar Ataxias, to determine whether age at onset is influenced by the size of the normal allele in eight causal (CAG)n-containing genes (ATXN1-3, 6-7, 17, ATN1 and HTT). We confirmed the negative effect of the expanded allele and detected threshold effects reflected by a quadratic association between age at onset and CAG size in spinocerebellar ataxia types 1, 3 and 6. We also evidenced an interaction between the expanded and normal alleles in trans in individuals with spinocerebellar ataxia types 1, 6 and 7. Except for individuals with spinocerebellar ataxia type 1, age at onset was also influenced by other (CAG)n-containing genes: ATXN7 in spinocerebellar ataxia type 2; ATXN2, ATN1 and HTT in spinocerebellar ataxia type 3; ATXN1 and ATXN3 in spinocerebellar ataxia type 6; and ATXN3 and TBP in spinocerebellar ataxia type 7. This suggests that there are biological relationships among these genes. The results were partially replicated in four independent populations representing 460 Caucasians and 216 Asian samples; the differences are possibly explained by ethnic or geographical differences. As the variability in age at onset is not completely explained by the effects of the causative and modifier sister genes, other genetic or environmental factors must also play a role in these diseases.
© The Author (2014). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  age at onset; modifier; spinocerebellar ataxia; trinucleotide repeat

Mesh:

Year:  2014        PMID: 24972706      PMCID: PMC4132646          DOI: 10.1093/brain/awu174

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  39 in total

Review 1.  Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology.

Authors:  G Stevanin; A Dürr; A Brice
Journal:  Eur J Hum Genet       Date:  2000-01       Impact factor: 4.246

2.  Searching for modulating effects of SCA2, SCA6 and DRPLA CAG tracts on the Machado-Joseph disease (SCA3) phenotype.

Authors:  L Jardim; I Silveira; M L Pereira; M do Céu Moreira; P Mendonça; J Sequeiros; R Giugliani
Journal:  Acta Neurol Scand       Date:  2003-03       Impact factor: 3.209

Review 3.  Pathogenesis of polyglutamine disorders: aggregation revisited.

Authors:  Andrej Michalik; Christine Van Broeckhoven
Journal:  Hum Mol Genet       Date:  2003-10-15       Impact factor: 6.150

4.  Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease.

Authors:  L Djoussé; B Knowlton; M Hayden; E W Almqvist; R Brinkman; C Ross; R Margolis; A Rosenblatt; A Durr; C Dode; P J Morrison; A Novelletto; M Frontali; R J A Trent; E McCusker; E Gómez-Tortosa; D Mayo; R Jones; A Zanko; M Nance; R Abramson; O Suchowersky; J Paulsen; M Harrison; Q Yang; L A Cupples; J F Gusella; M E MacDonald; R H Myers
Journal:  Am J Med Genet A       Date:  2003-06-15       Impact factor: 2.802

5.  Ethnic differences in the expression of neurodegenerative disease: Machado-Joseph disease in Africans and Caucasians.

Authors:  S H Subramony; Dena Hernandez; Amanda Adam; Stephanie Smith-Jefferson; Jennifer Hussey; Katrina Gwinn-Hardy; Timothy Lynch; Olga McDaniel; John Hardy; Matt Farrer; Andrew Singleton
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

Review 6.  Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.

Authors:  Ludger Schöls; Peter Bauer; Thorsten Schmidt; Thorsten Schulte; Olaf Riess
Journal:  Lancet Neurol       Date:  2004-05       Impact factor: 44.182

Review 7.  Genetic and environmental factors in the pathogenesis of Huntington's disease.

Authors:  Anton van Dellen; Anthony J Hannan
Journal:  Neurogenetics       Date:  2004-01-24       Impact factor: 2.660

8.  Modulation of age at onset in Huntington's disease and spinocerebellar ataxia type 2 patients originated from eastern India.

Authors:  Biswanath Chattopadhyay; Subho Ghosh; Prasanta K Gangopadhyay; Shaymal K Das; T Roy; Krishna K Sinha; Dilip K Jha; Subhash C Mukherjee; Ambar Chakraborty; Bhim S Singhal; Anup K Bhattacharya; Nitai P Bhattacharyya
Journal:  Neurosci Lett       Date:  2003-07-17       Impact factor: 3.046

9.  Spinocerebellar ataxias in Brazil--frequencies and modulating effects of related genes.

Authors:  Raphael Machado de Castilhos; Gabriel Vasata Furtado; Tailise Conte Gheno; Paola Schaeffer; Aline Russo; Orlando Barsottini; José Luiz Pedroso; Diego Z Salarini; Fernando Regla Vargas; Maria Angélica de Faria Domingues de Lima; Clécio Godeiro; Luiz Carlos Santana-da-Silva; Maria Betânia Pereira Toralles; Silvana Santos; Hélio van der Linden; Hector Yuri Wanderley; Paula Frassineti Vanconcelos de Medeiros; Eliana Ternes Pereira; Erlane Ribeiro; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2014-02       Impact factor: 3.847

10.  Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.

Authors:  A Matilla-Dueñas; T Ashizawa; A Brice; S Magri; K N McFarland; M Pandolfo; S M Pulst; O Riess; D C Rubinsztein; J Schmidt; T Schmidt; D R Scoles; G Stevanin; F Taroni; B R Underwood; I Sánchez
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

View more
  54 in total

1.  Dystonia and ataxia progression in spinocerebellar ataxias.

Authors:  Pei-Hsin Kuo; Shi-Rui Gan; Jie Wang; Raymond Y Lo; Karla P Figueroa; Darya Tomishon; Stefan M Pulst; Susan Perlman; George Wilmot; Christopher M Gomez; Jeremy D Schmahmann; Henry Paulson; Vikram G Shakkottai; Sarah H Ying; Theresa Zesiewicz; Khalaf Bushara; Michael D Geschwind; Guangbin Xia; S H Subramony; Tetsuo Ashizawa; Sheng-Han Kuo
Journal:  Parkinsonism Relat Disord       Date:  2017-10-23       Impact factor: 4.891

2.  Selective Forces Related to Spinocerebellar Ataxia Type 2.

Authors:  Lucas Schenatto Sena; Raphael Machado Castilhos; Eduardo Preusser Mattos; Gabriel Vasata Furtado; José Luiz Pedroso; Orlando Barsottini; Maria Marla Paiva de Amorim; Clecio Godeiro; Maria Luiza Saraiva Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2019-04       Impact factor: 3.847

Review 3.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

4.  ATXN3, ATXN7, CACNA1A, and RAI1 Genes and Mitochondrial Polymorphism A10398G Did Not Modify Age at Onset in Spinocerebellar Ataxia Type 2 Patients from South America.

Authors:  Fernanda S Pereira; Thais L Monte; Lucas D Locks-Coelho; Amanda S P Silva; Orlando Barsottini; José L Pedroso; Mario Cornejo-Olivas; Pilar Mazzetti; Clecio Godeiro; Fernando R Vargas; Maria-Angélica F D Lima; Hélio van der Linden; Maria Betânia Pereira Toralles; Paula F V Medeiros; Erlane Ribeiro; Pedro Braga-Neto; Diego Salarini; Raphael M Castilhos; Maria-Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

5.  Promoter Variation and Expression Levels of Inflammatory Genes IL1A, IL1B, IL6 and TNF in Blood of Spinocerebellar Ataxia Type 3 (SCA3) Patients.

Authors:  Mafalda Raposo; Conceição Bettencourt; Amanda Ramos; Nadiya Kazachkova; João Vasconcelos; Teresa Kay; Jácome Bruges-Armas; Manuela Lima
Journal:  Neuromolecular Med       Date:  2016-05-31       Impact factor: 3.843

Review 6.  Spinocerebellar ataxias: prospects and challenges for therapy development.

Authors:  Tetsuo Ashizawa; Gülin Öz; Henry L Paulson
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

7.  The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3.

Authors:  Shi-Rui Gan; Karla P Figueroa; Hao-Ling Xu; Susan Perlman; George Wilmot; Christopher M Gomez; Jeremy Schmahmann; Henry Paulson; Vikram G Shakkottai; Sarah H Ying; Theresa Zesiewicz; Khalaf Bushara; Michael D Geschwind; Guangbin Xia; S H Subramony; Liana Rosenthal; Tetsuo Ashizawa; Stefan M Pulst; Ning Wang; Sheng-Han Kuo
Journal:  Parkinsonism Relat Disord       Date:  2020-02-17       Impact factor: 4.891

Review 8.  Dilemma of multiple system atrophy and spinocerebellar ataxias.

Authors:  Ming Li; Qianqian Ma; Xing Zhao; Can Wang; Huijie Wu; Jinyao Li; Wei Yang
Journal:  J Neurol       Date:  2018-04-26       Impact factor: 4.849

9.  Spinocerebellar ataxia type 3/Machado-Joseph disease starting before adolescence.

Authors:  Karina Carvalho Donis; Jonas Alex Morales Saute; Ana Carolina Krum-Santos; Gabriel Vasata Furtado; Eduardo Preusser Mattos; Maria Luiza Saraiva-Pereira; Vanessa Leotti Torman; Laura Bannach Jardim
Journal:  Neurogenetics       Date:  2016-01-16       Impact factor: 2.660

10.  Spinocerebellar ataxia type 3 in Israel: phenotype and genotype of a Jew Yemenite subpopulation.

Authors:  Roy Zaltzman; Reuven Sharony; Colin Klein; Carlos R Gordon
Journal:  J Neurol       Date:  2016-08-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.